Retrospective study on the effectiveness of medroxyprogesterone acetate in the treatment of ER-positive/HER2-negative post-menopausal advanced breast cancer: an additional analysis of the JBCRG-C06 Safari study
Jpn J Clin Oncol. 2022 Dec 8:hyac184. doi: 10.1093/jjco/hyac184. Online ahead of print.NO ABSTRACTPMID:36484305 | DOI:10.1093/jjco/hyac184 (Source: Clinical Genitourinary Cancer)
Source: Clinical Genitourinary Cancer - December 9, 2022 Category: Cancer & Oncology Authors: Hidetoshi Kawaguchi Yutaka Yamamoto Shigehira Saji Norikazu Masuda Takahiro Nakayama Kenjiro Aogi Keisei Anan Shoichiro Ohtani Nobuaki Sato Toshimi Takano Eriko Tokunaga Seigo Nakamura Yoshie Hasegawa Masaya Hattori Tomomi Fujisawa Satoshi Morita Miki Yam Source Type: research
Retrospective study on the effectiveness of medroxyprogesterone acetate in the treatment of ER-positive/HER2-negative post-menopausal advanced breast cancer: an additional analysis of the JBCRG-C06 Safari study
Jpn J Clin Oncol. 2022 Dec 8:hyac184. doi: 10.1093/jjco/hyac184. Online ahead of print.NO ABSTRACTPMID:36484305 | DOI:10.1093/jjco/hyac184 (Source: Clinical Breast Cancer)
Source: Clinical Breast Cancer - December 9, 2022 Category: Cancer & Oncology Authors: Hidetoshi Kawaguchi Yutaka Yamamoto Shigehira Saji Norikazu Masuda Takahiro Nakayama Kenjiro Aogi Keisei Anan Shoichiro Ohtani Nobuaki Sato Toshimi Takano Eriko Tokunaga Seigo Nakamura Yoshie Hasegawa Masaya Hattori Tomomi Fujisawa Satoshi Morita Miki Yam Source Type: research
Anticoagulant therapy for women: implications for menstruation, pregnancy, and lactation
Hematology Am Soc Hematol Educ Program. 2022 Dec 9;2022(1):467-473. doi: 10.1182/hematology.2022000401.ABSTRACTEstrogen exposure, in the setting of pregnancy, the postpartum state, combined hormonal contraceptives (CHCs), or hormone therapy use, has been clearly associated with increased rates of venous thromboembolism (VTE). Although recurrence rates are low in these settings, up to 70% of anticoagulated menstruating individuals experience abnormal or heavy menstrual bleeding (HMB), which commonly results in iron deficiency with or without anemia. Patients taking rivaroxaban appear to experience higher rates of HMB compar...
Source: Hematology ASH Education Program - December 9, 2022 Category: Hematology Authors: Emma DeLoughery Bethany Samuelson Bannow Source Type: research
Anticoagulant therapy for women: implications for menstruation, pregnancy, and lactation
Hematology Am Soc Hematol Educ Program. 2022 Dec 9;2022(1):467-473. doi: 10.1182/hematology.2022000401.ABSTRACTEstrogen exposure, in the setting of pregnancy, the postpartum state, combined hormonal contraceptives (CHCs), or hormone therapy use, has been clearly associated with increased rates of venous thromboembolism (VTE). Although recurrence rates are low in these settings, up to 70% of anticoagulated menstruating individuals experience abnormal or heavy menstrual bleeding (HMB), which commonly results in iron deficiency with or without anemia. Patients taking rivaroxaban appear to experience higher rates of HMB compar...
Source: Hematology ASH Education Program - December 9, 2022 Category: Hematology Authors: Emma DeLoughery Bethany Samuelson Bannow Source Type: research
